Top Markets
Coin of the day
Eucrates Biomedical Acquisition Corp. Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp.

EUCR
Classement en actions #26003
Eucrates Biomedical Acquisition Corp. currently lacks substantial business... Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity acquisition, restructuring, or another comparable strategic alliance involving one or more enterprises. Specifically, it aims to find and acquire a company operating within the life sciences or broader healthcare sectors across North America and Europe. Established in 2020, this entity has its headquarters situated in New York, New York.
Prix de l'action
$10.04
Dernière synchronisation: 2023-05-05
Capitalisation boursière
$44.29M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Eucrates Biomedical Acquisition Corp. (EUCR)
Historique du rendement du dividende pour Eucrates Biomedical Acquisition Corp. (EUCR)
Le rendement du dividende (TTM) de Eucrates Biomedical Acquisition Corp. (symbole boursier : EUCR) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Eucrates Biomedical Acquisition Corp. (EUCR) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes